Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hepatogastroenterology ; 55(84): 887-90, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18705289

RESUMEN

BACKGROUND/AIMS: Pulmonary embolism (PE) is a potentially life threatening disease. Clinical signs and symptoms allow the clinician to determine the pretest probability of someone having pulmonary embolism but are insufficient to diagnose or rule out the condition. This paper aims to study the clinical presentation, identify the risk factors and evaluate the diagnostic strategies and management of patients with PE. METHODOLOGY: The medical files of 69 patients were searched, who were diagnosed with PE and who were admitted to the Surgical Care Unit. RESULTS: Dyspnea, pleuritic pain, haemoptysis, fever and cough were the most common presenting symptoms. Risk factors for PE were found in 90% of cases. D-dimers assay was elevated in all cases (100%) and the other diagnostic strategies used showed great accuracy in confirming the pretest probabilities of PE. It is of high importance that 75% of the patients had deep vein thrombosis as assessed by venous ultrasonography. Mortality due to PE was approximately 6.9%. CONCLUSIONS: PE can be often overlooked with hazardous consequences. Clinical evaluation in combination with spiral CT or lung scintigraphy and vein ultrasound and D-dimer level can establish the diagnosis in the majority of patients so that effective treatment to be started as soon as possible.


Asunto(s)
Cuidados Críticos , Diagnóstico por Imagen , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Complicaciones Posoperatorias/diagnóstico , Embolia Pulmonar/diagnóstico , Administración Oral , Adulto , Anciano , Anticoagulantes/efectos adversos , Anticoagulantes/uso terapéutico , Femenino , Heparina/efectos adversos , Heparina/uso terapéutico , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Tiempo de Tromboplastina Parcial , Complicaciones Posoperatorias/sangre , Complicaciones Posoperatorias/tratamiento farmacológico , Embolia Pulmonar/sangre , Embolia Pulmonar/tratamiento farmacológico , Factores de Riesgo , Warfarina/efectos adversos , Warfarina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA